Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 5Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Sezary Syndrome 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Mycosis Fungoides 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Hairy Cell 1Leukemia, Biphenotypic, Acute 1Intraocular Lymphoma 1Inflammatory Breast Neoplasms 1Immunoblastic Lymphadenopathy 1Dendritic Cell Sarcoma, Interdigitating 1Cardiotoxicity 1Burkitt Lymphoma 1Breast Neoplasms 1Blast Crisis 1

Interventions

Doxorubicin 5Cyclophosphamide 3Trastuzumab 2Docetaxel 2Dexrazoxane 2empagliflozin 1Taxes 1Tamoxifen 1Razoxane 1Radiotherapy 1Radiation 1Paclitaxel 1Neoadjuvant Therapy 1Methotrexate 1Metformin 1Leucovorin 1High-Intensity Interval Training 1Hematologic Tests 1Filgrastim 1Exercise 1Epirubicin 1Echocardiography 1Cisplatin 1Chemotherapy, Adjuvant 1Carvedilol 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Cardiotoxicity × Razoxane × Clear all
NCT00016276 2013-01-16

Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer

National Cancer Institute (NCI)

Phase 3 Terminated
396 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡